Anti-cyclic citrullinated peptide antibody related to the disease progression and extra-articular involvement in patient with rheumatoid arthritis in Hospital Universiti Sains Malaysia

BACKGROUND : Rheumatoid arthritis (RA) is a chronic debilitating inflammatory disease affecting mainly the joint and surrounding tissue, and also involved other extra articular structures in the body. It can lead to destruction of bone and cartilage which may cause severe disability to the patien...

Full description

Saved in:

Bibliographic Details
Main Author:	Sulaiman, Farah Nadiah
Format:	Thesis
Language:	English
Published:	2017
Subjects:	RC Internal medicine
Online Access:	http://eprints.usm.my/44905/1/Dr.%20Farah%20Nadiah%20Sulaiman-24%20pages.pdf
Tags:	Add Tag No Tags, Be the first to tag this record!

id	my-usm-ep.44905
record_format	uketd_dc
spelling	my-usm-ep.449052020-10-22T03:03:16Z Anti-cyclic citrullinated peptide antibody related to the disease progression and extra-articular involvement in patient with rheumatoid arthritis in Hospital Universiti Sains Malaysia 2017 Sulaiman, Farah Nadiah RC Internal medicine BACKGROUND : Rheumatoid arthritis (RA) is a chronic debilitating inflammatory disease affecting mainly the joint and surrounding tissue, and also involved other extra articular structures in the body. It can lead to destruction of bone and cartilage which may cause severe disability to the patient. Other than rheumatoid factor, anti-cyclic citrullinate peptide (anti-CCP) antibody is another biomarker that can be used to diagnose RA with higher sensitivity and specificity. OBJECTIVE : To evaluate the significant of anti-CCP antibody in predicting the disease activity, and disease progression in term of radiological and extra articular manifestation upon diagnosis in patient with rheumatoid arthritis in HUSM. METHODS : This was a cross sectional study with retrospective record review. A total of 159 patients who were diagnosed as rheumatoid arthritis based on 2010 EULAR criteria for RA since 2010 until 2017 under rheumatology clinic HUSM follow up were included in this study. Exclusion criteria include age of 16 years old or less at the onset of diagnosis, probable RA, and overlap syndromes or related to other connective tissue disease. The data was retrieved from medical record for rheumatoid factor, anti-CCP antibody, assessment of disease activity using DAS28 ESR calculator, plain radiograph of hands or feet, and extra-articular manifestation in term ofassessment of rheumatoid nodule, pulmonary involvement, Felty syndrome, vasculitis and anemia upon diagnosis. RESULTS : From a total of 159 patients, 134 (84.3%) patients were female with majority ethnic group was Malay (87.4%). The mean for age was 48.3 years old; ranging from 17 to 79. The prevalence of anti-CCP antibody was 52.2% (95% CI 0.44 to 0.60) and the percentage of positive rheumatoid factor was 62.3%. Mean DAS28-ESR score for total patients was 4.74 which medium and high disease activity were predominant upon diagnosis. 36.5% of patients had radiological involvement and 30.8% of patients had extra-articular involvement manifested by rheumatoid nodule, pulmonary involvement, and anemia. Patients with both positive rheumatoid factor and anti-CCP antibody was significantly higher than other groups (n=83; 73.5%) (p-value 0.002). For radiological involvement, it was significantly higher in anti-CCP antibody positive group. However, there was no significant difference between mean and classes of disease activity score, and extra-articular manifestations between different anti-CCP antibody positivity group. Extra-articular manifestations was not associated with high disease activity upon diagnosis of RA. CONCLUSION : In conclusion, there was significant association between anti-CCP antibody positivity and positive rheumatoid factor and radiological involvement, however no significant difference found in mean disease activity and extra-articular manifestation upon diagnosis in patient withRA in HUSM. Extra-articular manifestations was not associated with high disease activity upon diagnosis of RA. 2017 Thesis http://eprints.usm.my/44905/ http://eprints.usm.my/44905/1/Dr.%20Farah%20Nadiah%20Sulaiman-24%20pages.pdf application/pdf en public masters Universiti Sains Malaysia Pusat Pengajian Sains Perubatan
institution	Universiti Sains Malaysia
collection	USM Institutional Repository
language	English
topic	RC Internal medicine
spellingShingle	RC Internal medicine Sulaiman, Farah Nadiah Anti-cyclic citrullinated peptide antibody related to the disease progression and extra-articular involvement in patient with rheumatoid arthritis in Hospital Universiti Sains Malaysia
description	BACKGROUND : Rheumatoid arthritis (RA) is a chronic debilitating inflammatory disease affecting mainly the joint and surrounding tissue, and also involved other extra articular structures in the body. It can lead to destruction of bone and cartilage which may cause severe disability to the patient. Other than rheumatoid factor, anti-cyclic citrullinate peptide (anti-CCP) antibody is another biomarker that can be used to diagnose RA with higher sensitivity and specificity. OBJECTIVE : To evaluate the significant of anti-CCP antibody in predicting the disease activity, and disease progression in term of radiological and extra articular manifestation upon diagnosis in patient with rheumatoid arthritis in HUSM. METHODS : This was a cross sectional study with retrospective record review. A total of 159 patients who were diagnosed as rheumatoid arthritis based on 2010 EULAR criteria for RA since 2010 until 2017 under rheumatology clinic HUSM follow up were included in this study. Exclusion criteria include age of 16 years old or less at the onset of diagnosis, probable RA, and overlap syndromes or related to other connective tissue disease. The data was retrieved from medical record for rheumatoid factor, anti-CCP antibody, assessment of disease activity using DAS28 ESR calculator, plain radiograph of hands or feet, and extra-articular manifestation in term ofassessment of rheumatoid nodule, pulmonary involvement, Felty syndrome, vasculitis and anemia upon diagnosis. RESULTS : From a total of 159 patients, 134 (84.3%) patients were female with majority ethnic group was Malay (87.4%). The mean for age was 48.3 years old; ranging from 17 to 79. The prevalence of anti-CCP antibody was 52.2% (95% CI 0.44 to 0.60) and the percentage of positive rheumatoid factor was 62.3%. Mean DAS28-ESR score for total patients was 4.74 which medium and high disease activity were predominant upon diagnosis. 36.5% of patients had radiological involvement and 30.8% of patients had extra-articular involvement manifested by rheumatoid nodule, pulmonary involvement, and anemia. Patients with both positive rheumatoid factor and anti-CCP antibody was significantly higher than other groups (n=83; 73.5%) (p-value 0.002). For radiological involvement, it was significantly higher in anti-CCP antibody positive group. However, there was no significant difference between mean and classes of disease activity score, and extra-articular manifestations between different anti-CCP antibody positivity group. Extra-articular manifestations was not associated with high disease activity upon diagnosis of RA. CONCLUSION : In conclusion, there was significant association between anti-CCP antibody positivity and positive rheumatoid factor and radiological involvement, however no significant difference found in mean disease activity and extra-articular manifestation upon diagnosis in patient withRA in HUSM. Extra-articular manifestations was not associated with high disease activity upon diagnosis of RA.
format	Thesis
qualification_level	Master's degree
author	Sulaiman, Farah Nadiah
author_facet	Sulaiman, Farah Nadiah
author_sort	Sulaiman, Farah Nadiah
title	Anti-cyclic citrullinated peptide antibody related to the disease progression and extra-articular involvement in patient with rheumatoid arthritis in Hospital Universiti Sains Malaysia
title_short	Anti-cyclic citrullinated peptide antibody related to the disease progression and extra-articular involvement in patient with rheumatoid arthritis in Hospital Universiti Sains Malaysia
title_full	Anti-cyclic citrullinated peptide antibody related to the disease progression and extra-articular involvement in patient with rheumatoid arthritis in Hospital Universiti Sains Malaysia
title_fullStr	Anti-cyclic citrullinated peptide antibody related to the disease progression and extra-articular involvement in patient with rheumatoid arthritis in Hospital Universiti Sains Malaysia
title_full_unstemmed	Anti-cyclic citrullinated peptide antibody related to the disease progression and extra-articular involvement in patient with rheumatoid arthritis in Hospital Universiti Sains Malaysia
title_sort	anti-cyclic citrullinated peptide antibody related to the disease progression and extra-articular involvement in patient with rheumatoid arthritis in hospital universiti sains malaysia
granting_institution	Universiti Sains Malaysia
granting_department	Pusat Pengajian Sains Perubatan
publishDate	2017
url	http://eprints.usm.my/44905/1/Dr.%20Farah%20Nadiah%20Sulaiman-24%20pages.pdf
_version_	1747821422408892416

Anti-cyclic citrullinated peptide antibody related to the disease progression and extra-articular involvement in patient with rheumatoid arthritis in Hospital Universiti Sains Malaysia

Similar Items